module 205.1 en
TRANSCRIPT
![Page 1: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/1.jpg)
MACROVASCULAR DISEASE
![Page 2: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/2.jpg)
Objectives
![Page 3: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/3.jpg)
Macrovascular disease
![Page 4: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/4.jpg)
Macrovascular disease
![Page 5: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/5.jpg)
What is atherosclerosis?
![Page 6: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/6.jpg)
Coronary heart disease
![Page 7: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/7.jpg)
Prevalence (%) ranges for coronary heart disease
![Page 8: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/8.jpg)
Coronary heart disease in diabetes
![Page 9: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/9.jpg)
Coronary heart disease in diabetes
![Page 10: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/10.jpg)
Myocardial infarction and diabetes
![Page 11: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/11.jpg)
Prevention
![Page 12: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/12.jpg)
Activity
![Page 13: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/13.jpg)
Controlling risk factors
![Page 14: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/14.jpg)
Activity
![Page 15: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/15.jpg)
Dyslipidaemia
![Page 16: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/16.jpg)
Lipid Targets
![Page 17: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/17.jpg)
Lipids: treatment
![Page 18: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/18.jpg)
Lipids: side effects of statins
![Page 19: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/19.jpg)
Activity
![Page 20: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/20.jpg)
Hypertension
![Page 21: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/21.jpg)
Hypertension
![Page 22: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/22.jpg)
Hypertension target
![Page 23: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/23.jpg)
Treatment
![Page 24: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/24.jpg)
Anti-hypertensive medications
![Page 25: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/25.jpg)
Potential side effects
![Page 26: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/26.jpg)
Hypertension – the final word
![Page 27: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/27.jpg)
Activity
![Page 28: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/28.jpg)
Heart failure in diabetes
![Page 29: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/29.jpg)
Treatment of heart failure
![Page 30: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/30.jpg)
Cerebrovascular disease
![Page 31: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/31.jpg)
Summary
![Page 32: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/32.jpg)
References
![Page 33: Module 205.1 en](https://reader036.vdocuments.us/reader036/viewer/2022062901/58f9b165760da3da068bc04a/html5/thumbnails/33.jpg)
References